213 related articles for article (PubMed ID: 19430729)
1. Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.
Aaberg-Jessen C; Christensen K; Offenberg H; Bartels A; Dreehsen T; Hansen S; Schrøder HD; Brünner N; Kristensen BW
J Neurooncol; 2009 Oct; 95(1):117-128. PubMed ID: 19430729
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.
Aaberg-Jessen C; Sørensen MD; Matos ALSA; Moreira JM; Brünner N; Knudsen A; Kristensen BW
BMC Cancer; 2018 Mar; 18(1):270. PubMed ID: 29523123
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
Ramachandran RK; Sørensen MD; Aaberg-Jessen C; Hermansen SK; Kristensen BW
PLoS One; 2017; 12(2):e0172234. PubMed ID: 28234925
[TBL] [Abstract][Full Text] [Related]
4. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N
Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.
Aaberg-Jessen C; Fogh L; Sørensen MD; Halle B; Brünner N; Kristensen BW
Pathol Oncol Res; 2019 Jan; 25(1):59-69. PubMed ID: 28963609
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients.
Aaberg-Jessen C; Halle B; Jensen SS; Müller S; Rømer UM; Pedersen CB; Brünner N; Kristensen BW
J Neurooncol; 2016 Dec; 130(3):439-448. PubMed ID: 27619981
[TBL] [Abstract][Full Text] [Related]
7. Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.
Mohanam S; Wang SW; Rayford A; Yamamoto M; Sawaya R; Nakajima M; Liotta LA; Nicolson GL; Stetler-Stevenson WG; Rao JS
Clin Exp Metastasis; 1995 Jan; 13(1):57-62. PubMed ID: 7820957
[TBL] [Abstract][Full Text] [Related]
8. ATM and p53 combined analysis predicts survival in glioblastoma multiforme patients: A clinicopathologic study.
Romano FJ; Guadagno E; Solari D; Borrelli G; Pignatiello S; Cappabianca P; Del Basso De Caro M
J Cell Biochem; 2018 Jun; 119(6):4867-4877. PubMed ID: 29369420
[TBL] [Abstract][Full Text] [Related]
9. TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas.
Rorive S; Lopez XM; Maris C; Trepant AL; Sauvage S; Sadeghi N; Roland I; Decaestecker C; Salmon I
Mod Pathol; 2010 Oct; 23(10):1418-28. PubMed ID: 20693981
[TBL] [Abstract][Full Text] [Related]
10. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of cyclin A in astrocytic tumours.
Chakrabarty A; Bridges LR
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):239-45. PubMed ID: 9717190
[TBL] [Abstract][Full Text] [Related]
12. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
[TBL] [Abstract][Full Text] [Related]
13. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
14. CD133 identifies perivascular niches in grade II-IV astrocytomas.
Christensen K; Schrøder HD; Kristensen BW
J Neurooncol; 2008 Nov; 90(2):157-70. PubMed ID: 18612800
[TBL] [Abstract][Full Text] [Related]
15. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
[TBL] [Abstract][Full Text] [Related]
16. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
Gunal A; Onguru O; Safali M; Beyzadeoglu M
Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C
Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373
[TBL] [Abstract][Full Text] [Related]
18. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival.
Capper D; Mittelbronn M; Goeppert B; Meyermann R; Schittenhelm J
Neuropathol Appl Neurobiol; 2010 Apr; 36(3):183-97. PubMed ID: 20132490
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
[TBL] [Abstract][Full Text] [Related]
20. Transcription analysis of TIMP-1 and NM23-H1 genes in glioma cell invasion.
Nasser JA; Falavigna A; Ferraz F; Duigou G; Bruce J
Arq Neuropsiquiatr; 2006 Sep; 64(3B):774-80. PubMed ID: 17057884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]